Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.90
Bid: 2.80
Ask: 3.00
Change: 0.00 (0.00%)
Spread: 0.20 (7.143%)
Open: 2.90
High: 2.90
Low: 2.84
Prev. Close: 2.90
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

10 Jan 2018 15:19

RNS Number : 5221B
Allergy Therapeutics PLC
10 January 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Allergy Therapeutics PLC

LEI: 213800PQ7AHK7KGVOE23

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Placing of Shares

3. Details of person subject to the notification obligationiv

Name

Invesco Ltd.

City and country of registered office (if applicable)

1555 Peachtree Street NE, Suite 1800,

Atlanta, GA 30309 United States

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

09-01-2018

6. Date on which issuer notified (DD/MM/YYYY):

10-01-2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4.81%

0

4.81%

594,117,768

Position of previous notification (if

applicable)

5.62%

0

5.62%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

 

GB00B02LCQ05

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

28,618,373

4.81%

SUBTOTAL 8. A

28,618,373

4.81%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Invesco Asset

Management Limited.

4.81%

0

4.81%

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

Invesco (UK) Ltd.

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

Place of completion

Henley-on-Thames

Date of completion

10-01-2018

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEASFEFFPPEFF
Date   Source Headline
30th Sep 20147:00 amRNSAmendment of 2012 Loan Note term
29th Sep 201410:52 amRNSHolding(s) in Company
24th Sep 20141:18 pmRNSExercise of Options
24th Sep 201412:12 pmRNSAnnual Report and Accounts
22nd Sep 20147:00 amRNSFinal Results
4th Sep 20147:00 amRNSShareholder update
24th Jul 20147:00 amRNSNotice of Results and Trading Update
17th Jul 20143:10 pmRNSHolding(s) in Company
30th Apr 20147:01 amRNSWorthing Facility Licence Renewal
25th Apr 20147:00 amRNSDirector/PDMR Shareholding
17th Apr 20147:00 amRNSExtension of Convertible Loan Note
24th Mar 20147:00 amRNSHalf Yearly Report
17th Mar 20147:00 amRNSNotice of Results
12th Mar 20147:00 amRNSShareholder update
19th Feb 20147:00 amRNSHealth Canada approves submission of CTA
27th Jan 20147:00 amRNSResults published in highly respected journal
14th Jan 20147:00 amRNSTrading Update and Notice of Results
20th Nov 20131:19 pmRNSResult of AGM
20th Nov 20137:00 amRNSBusiness and R&D Update
16th Oct 20134:21 pmRNSAnnual Report and Accounts
9th Oct 20138:48 amRNSNotification under AIM Rule Schedule Two (g)
27th Sep 20138:33 amRNSChange of Adviser
19th Sep 20133:51 pmRNSHolding(s) in Company
16th Sep 20137:00 amRNSFinal Results
3rd Jun 201310:23 amRNSHolding(s) in Company
15th May 201310:20 amRNSGrant of Options
8th May 201310:39 amRNSHolding(s) in Company
8th May 201310:18 amRNSHolding(s) in Company
25th Mar 20137:00 amRNSHalf Yearly Report
11th Mar 20137:00 amRNSNotice of results and shareholder update
11th Mar 20137:00 amRNSUS patent granted
22nd Jan 201310:41 amRNSExercise of Options
28th Dec 20127:00 amRNSTotal Voting Rights
27th Dec 201212:02 pmRNSUpdate on Lincoln Medical Final
19th Dec 20123:14 pmRNSGrant of Options
10th Dec 201211:44 amRNSDirector/PDMR Shareholding
5th Dec 20123:42 pmRNSTotal Voting Rights
4th Dec 201212:40 pmRNSExercise of Options
30th Nov 20129:00 amRNSTotal Voting Rights
21st Nov 20122:23 pmRNSHolding(s) in Company
20th Nov 20122:25 pmRNSExercise of Options
14th Nov 201211:41 amRNSResult of AGM
9th Nov 201212:12 pmRNSDirector/PDMR Shareholding
16th Oct 20123:54 pmRNSAnnual Financial Report
4th Oct 20123:57 pmRNSHolding(s) in Company
17th Sep 20127:00 amRNSFinal Results
30th Aug 201211:14 amRNSNotice of results and shareholder update
3rd Aug 20127:00 amRNSFDA Clinical Hold Lifted
31st May 20122:34 pmRNSHolding(s) in Company
23rd May 201211:23 amRNSVoluntary recall of Anapen by Lincoln Medical

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.